Power supply for an implantable subcutaneous cardioverter-defibrillator

• US 7,720,536 B2
• Filed: 06/06/2006
• Issued: 05/18/2010
• Est. Priority Date: 09/18/2000
• Status: Expired due to Fees

• Current Assignee: Cameron Health Inc (Boston Scientific Corporation)
• Original Assignee: Cameron Health Inc (Boston Scientific Corporation)
• Inventors: Rissmann, William J., Bardy, Gust H., Cappato, Riccardo
• Primary Examiner(s): Bockelman; Mark W
• Assistant Examiner(s): So; Elizabeth K
• Application Number:
  US11/447,531
• Publication Number:
  US 20060229682A1
• Time in Patent Office: 1,442 Days
• Field of Search: 607/4, 607/5, 607 7- 9
• US Class Current: 607/4
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators
• CPC Class Codes: A61N 1/378 Electrical supply
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3968 Constructional arrangements, e.g. casings A61N1/375 takes precedence
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence

Abstract

A power supply for an implantable cardioverter-defibrillator for subcutaneous positioning between the third rib and the twelfth rib and for providing cardioversion/defibrillation energy to the heart, the power supply comprising a capacitor subsystem for storing the cardioversion/defibrillation energy for delivery to the patient'"'"'s heart; and a battery subsystem electrically coupled to the capacitor subsystem for providing electrical energy to the capacitor subsystem.

Claims

1. A method of treating a patient comprising:

providing an implantable cardiac stimulus system comprising operational circuitry for detecting and analyzing cardiac function and outputting cardiac stimulus, and a housing that contains the operational circuitry, attached to a lead;

implanting the cardiac stimulus system into a patient by establishing a subcutaneous space for receiving the cardiac stimulus system and inserting the cardiac stimulus system into the subcutaneous space without introducing a transvenous lead for association with the operational circuitry such that all components are disposed between the skin and the ribcage of the patient by placing the housing at the left posterior axillary line and the lead in the inframammary crease, ending in the anterior precordial region of the patient;

detecting and analyzing cardiac function to determine whether cardiac stimulus is indicated; and

if cardiac stimulus is indicated, delivering cardioversion/defibrillation energy using the operational circuitry.

2. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 40 to approximately 210 joules.

3. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 40 to approximately 60 joules.

4. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 60 to approximately 85 joules.

5. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 85 to approximately 115 joules.

6. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 115 to approximately 140 joules.

7. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 140 to approximately 160 joules.

8. The method of claim 1, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 160 to approximately 210 joules.

9. The method of claim 1, wherein the implantable cardiac stimulus system consists of:

the housing which contains the operational circuitry; and

a lead assembly comprising a single elongate lead with at least one electrical conductor disposed therein and at least one lead electrode disposed thereon;

wherein;

the operational circuitry comprises at least analog and digital circuitry and a power supply and energy storage means; and

the lead assembly is configured to be secured to the housing at least when the cardiac stimulus system is in an implanted condition.

10. The method of claim 9, wherein the housing comprises an electrode and the step of delivering cardioversion/defibrillation energy uses the housing electrode as:

either an anode or a cathode if the cardioversion/defibrillation energy is provided in a monophasic waveform;

or

both anode and cathode, sequentially in either order, if the cardioversion/defibrillation energy is provided in a biphasic waveform.

11. A method of treating a patient comprising:

providing an implantable cardiac stimulus system having at least operational circuitry for detecting and analyzing cardiac function and outputting cardiac stimulus, a lead carrying a plurality of electrodes and means for housing the operational circuitry attached to the lead;

implanting the cardiac stimulus system into a patient by establishing a subcutaneous space for receiving the cardiac stimulus system and inserting the cardiac stimulus system into the subcutaneous space without introducing a transvenous lead for association with the operational circuitry such that all components are placed between the skin and the ribcage of the patient by placing the housing at the left posterior axillary line and the lead in the inframammary crease, ending in the anterior precordial region of the patient;

detecting and analyzing cardiac function to determine whether cardiac stimulus is indicated; and

if cardiac stimulus is indicated, delivering cardioversion/defibrillation energy using the operational circuitry.

12. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 40 to approximately 210 joules.

13. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 40 to approximately 60 joules.

14. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 60 to approximately 85 joules.

15. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 85 to approximately 115 joules.

16. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 115 to approximately 140 joules.

17. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 140 to approximately 160 joules.

18. The method of claim 11, wherein the cardioversion/defibrillation energy is an amount in the range of approximately 160 to approximately 210 joules.

19. The method of claim 11, wherein the implantable cardiac stimulus system consists of:

the housing means; and

a lead assembly comprising a single elongate lead with at least one electrical conductor disposed therein and at least one lead electrode disposed thereon;

wherein;

the operational circuitry comprises at least analog and digital circuitry and a power supply and energy storage means; and

the lead assembly is configured to be secured to the housing means at least when the cardiac stimulus system is in an implanted condition.

20. The method of claim 19, wherein the housing means comprises an electrode and the step of delivering cardioversion/defibrillation energy uses the housing means electrode as:

either an anode or a cathode if the cardioversion/defibrillation energy is provided in a monophasic waveform;

or

both anode and cathode, sequentially in either order, if the cardioversion/defibrillation energy is provided in a biphasic waveform.